Radiofrequency ablation for patients with colorectal cancer and unresectable liver metastasis

Clinical Colorectal Cancer

Volumn 5, Issue 5, 2006, Pages 318-320

  Gibson, Tara Beers ^c   Becerra, Carlos ^c   Chu, Edward ^a,b  

^a Section of Hematology and Medical Oncology   (United States)

^b YALE CANCER CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ARTICLE; CANCER CENTER; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CRYOSURGERY; HUMAN; INTERMETHOD COMPARISON; LAPAROTOMY; LENGTH OF STAY; LIVER METASTASIS; RADIOFREQUENCY ABLATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR VOLUME;

EID: 33244494253     PISSN: 15330028     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1533-0028(11)70201-8     Document Type: Article

References (15)

1. Geoghan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg 1999; 86:158-169.
2. Cady B, Jenkins RL, Steele GD Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 1998; 227:566-571.
3. Bengtsson G, Carlsson G, Harstrom L. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981; 141:586-589.
4. Stangl R, Altendorf-Hofmann A, Charnley RM, et al. Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343:1405-1410.
5. Blumgart LH, Allison DJ. Resection and embolization in the management of secondary hepatic tumors. World J Surg 1982; 61:32-45.
6. Harmon K, Ryan J, Bichl T, et al. Benefits and safety of hepatic resection for colorectal metastases. Am J Surg 1999; 177:402-404.
7. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection based on 1568 patients. Cancer 1996; 77:1254-1262.
8. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992; 10:1112-1118.
9. Kemeny N, Daly J, Reichman B, et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal cancer: a randomized trial. Ann Intern Med 1987; 107:459-465.
10. Scudamore CH, Patterson EJ, Shapiro AM, et al. Liver tumor ablation techniques. J Invest Surg 1997; 10:157-164.
11. White TJ, Roy-Choudhury SH, Breen DJ, et al. Percutaneous radiofrequency ablation of colorectal hepatic metastases: initial experience. Dig Surg 2004; 21:314-320.
12. Bilchik AJ, Wood TF, Allegra D, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms. Arch Surg 2000; 135:657-664.
13. Bleicher RJ, Allegra DP, Nora DT, et al. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003; 10:52-58.
14. Bilchik, A. Radiofrequency ablation of liver metastases. Presented at: the Fourth International Colorectal Cancer Congress; October 14-16, 2005; Aventura, FL.
15. Treatment of unresectable colorectal metastases by radiofrequency ablation combined or not with resection, with or without neoadjuvant chemotherapy. Available at: www.clinicaltrials.gov. Accessed January 20, 2006.